期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
情绪稳定剂和苯二氮[艹卓]类药对无抽搐电休克治疗诱导癫痫发作的影响 被引量:1
1
作者 苏德振 翁深宏 +8 位作者 姚丽华 王利 王迎 宗小芬 南彩 梅胜兰 黄磊 徐顺生 王高华 《临床精神医学杂志》 CAS 2022年第1期9-12,共4页
目的:探讨情绪稳定剂(MSs)和苯二氮[艹卓]类药(BZs)对无抽搐电休克治疗(MECT)诱导癫痫发作阈值、刺激电量和癫痫发作持续时间的影响。方法:347例接受MECT治疗的精神障碍患者根据用药情况分为MSs组(79例)、BZs组(87例)、合用组(118例)和... 目的:探讨情绪稳定剂(MSs)和苯二氮[艹卓]类药(BZs)对无抽搐电休克治疗(MECT)诱导癫痫发作阈值、刺激电量和癫痫发作持续时间的影响。方法:347例接受MECT治疗的精神障碍患者根据用药情况分为MSs组(79例)、BZs组(87例)、合用组(118例)和对照组(63例),采用MECT从低剂量开始滴定刺激电量。记录阈值电量、每次治疗电量和癫痫发作持续时间,并进行组间比较。结果:各组MECT阈值电量、平均刺激电量及诱导的癫痫发作持续时间比较差异有统计学意义(P均<0.01);各组阈值电量依次为合用组>MSs组>BZs组>对照组;平均刺激电量依次为合用组>MSs组>BZs组>对照组;诱导癫痫发作持续时间依次为对照组>BZs组>MSs组>合用组。结论:服用MSs或BZs的精神障碍患者进行MECT治疗时出现癫痫发作时间缩短和刺激电量增加;其中服用MSs对其的影响大于BZs;MSs和BZs合用时对此影响更大。 展开更多
关键词 无抽搐电休克治疗 癫痫发作 发作阈值 情绪稳定剂 苯二氮[艹卓]类药
下载PDF
Shenmai Injection Attenuates Myocardial Ischemia/Reperfusion Injury by Targeting Nrf2/GPX4 Signalling-Mediated Ferroptosis 被引量:9
2
作者 mei sheng-lan XIA Zhong-yuan +3 位作者 QIU Zhen JIA Yi-fan ZHOU Jin-jian ZHOU Bin 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2022年第11期983-991,共9页
Objective:To examine the effect of Shenmai Injection(SMJ)on ferroptosis during myocardial ischemia reperfusion(I/R)injury in rats and the underlying mechanism.Methods:A total of 120SPF-grade adult male SD rats,weighin... Objective:To examine the effect of Shenmai Injection(SMJ)on ferroptosis during myocardial ischemia reperfusion(I/R)injury in rats and the underlying mechanism.Methods:A total of 120SPF-grade adult male SD rats,weighing 220–250 g were randomly divided into different groups according to a random number table.Myocardial I/R model was established by occluding the left anterior descending artery for 30 min followed by 120 min of reperfusion.SMJ was injected intraperitoneally at the onset of 120 min of reperfusion,and erastin(an agonist of ferroptosis),ferrostatin-1(Fer-1,an inhibitor of ferroptosis)and ML385(an inhibitor of nuclear factor erythroid-2 related factor 2(Nrf2))were administered intraperitoneally separately 30 min before myocardial ischemia as different pretreatments.Cardiac function before ischemia,after ischemia and after reperfusion was analysed.Pathological changes in the myocardium and the ultrastructure of cardiomyocytes were observed,and the myocardial infarction area was measured.Additionally,the concentration of Fein heart tissues and the levels of creatine kinase-MB(CK-MB),troponin I(cTnI),malondialdehyde(MDA)and superoxide dismutase(SOD)in serum were measured using assay kits,and the expressions of Nrf2,glutathione peroxidase 4(GPX4)and acyl-CoA synthetase long-chain family member 4(ACSL4)were examined by Western blot.Results:Compared with the sham group,I/R significantly injured heart tissues,as evidenced by the disordered,ruptured and oedematous myocardial fibres;the increases in infarct size,serum CK-MB,cTnI and MDA levels,and myocardial Feconcentrations;and the decreases in SOD activity(P<0.05).These results were accompanied by ultrastructural alterations to the mitochondria,increased expression of ACSL4 and inhibited the activation of Nrf2/GPX4 signalling(P<0.05).Compared with the I/R group,pretreatment with 9 mL/kg SMJ and 2 mg/kg Fer-1 significantly reduced myocardial I/R injury,Feconcentrations and ACSL4 expression and attenuated mitochondrial impairment,while 14 mg/kg erastin exacerbated myocardial I/R injury(P<0.05).In addition,cardioprotection provided by 9 mL/kg SMJ was completely reversed by ML385,as evidenced by the increased myocardial infarct size,CK-MB,cTnI,MDA and Feconcentrations,and the decreased SOD activity(P<0.05).Conclusions:Ferroptosis is involved in myocardial I/R injury.Pretreatment with SMJ alleviated myocardial I/R injury by activating Nrf2/GPX4 signalling-mediated ferroptosis,thereby providing a strategy for the prevention and treatment of ischemic heart diseases. 展开更多
关键词 ferroptosis Shenmai Injection myocardial ischemia reperfusion injury PRETREATMENT
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部